Posted inBiotechnology
BMS keeps axing deals inked under old leadership, this time culling cell therapy pacts with Century, Immatics
Bristol Myers Squibb has terminated cell therapy pacts with two biotechs amid "ongoing portfolio prioritization efforts” within the Big Pharma,…